Showing results (1881-1890 of 1,950) with videos related to
Sort By:
Pageof 195
Nature Medicine|August 24, 2021
Mitochondrial DNA variants modulate N-formylmethionine, proteostasis and risk of late-onset human diseasesNa Cai, Aurora Gomez-Duran, Ekaterina Yonova-Doing, et al.The Journal of Liquid Biopsy|July 28, 2026
Associations between early changes in circulating tumor DNA (ctDNA) and outcomes across randomized trials: Insights from the ctMoniTR projectHillary S Andrews, Nevine Zariffa, Emily M Goren, et al.BMJ Open|January 24, 2023
Protocol for a MULTI-centre feasibility study to assess the use of 99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)Hannah Warren, Thomas Wagner, Michael A Gorin, et al.Plos Medicine|November 30, 2016
Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation AnalysisLuca A Lotta, Robert A Scott, Stephen J Sharp, et al.Nature|March 26, 2025
Long-term impact and biological recovery in a deep-sea mining trackDaniel O B Jones, Maria Belen Arias, Loïc Van Audenhaege, et al.Environmental Research|May 2, 2022
Gaseous air pollutants and DNA methylation in a methylome-wide association study of an ethnically and environmentally diverse population of U.S. adultsKatelyn M Holliday, Rahul Gondalia, Antoine Baldassari, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2025
[99mTc]Tc-sestamibi SPECT/CT for the diagnosis of kidney tumours: a multi-centre feasibility study (MULTI-MIBI Study)Hannah Warren, Thomas Wagner, Soha El-Sheikh, et al.Diabetes|September 12, 2019
Epigenome-Wide Association Study of Incident Type 2 Diabetes in a British Population: EPIC-Norfolk StudyAlexia Cardona, Felix R Day, John R B Perry, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2012
A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumorsMarcus Schmidt, Birte Hellwig, Seddik Hammad, et al.Journal of Medicinal Chemistry|March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitorYujia Dai, Kresna Hartandi, Zhiqin Ji, et al.Pageof 195